Peer Review History

Original SubmissionOctober 12, 2019
Decision Letter - Jonathan H Sherman, Editor

PONE-D-19-26376

A New Simple Brain Segmentation Method for Extracerebral Intracranial Tumors

PLOS ONE

Dear Mrs dongdong,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

We would appreciate receiving your revised manuscript by Jan 09 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled 'Manuscript'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Jonathan H Sherman

Academic Editor

PLOS ONE

Journal Requirements:

1. When submitting your revision, we need you to address these additional requirements.

Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for including your ethics statement: The study was approved by the medical ethical committee of our hospital, and informed consent was deserted because of the retrospective collection of this study.

Please amend your current ethics statement to include the full name of the ethics committee/institutional review board(s) that approved your specific study.

Once you have amended this/these statement(s) in the Methods section of the manuscript, please add the same text to the “Ethics Statement” field of the submission form (via “Edit Submission”).

For additional information about PLOS ONE ethical requirements for human subjects research, please refer to http://journals.plos.org/plosone/s/submission-guidelines#loc-human-subjects-research.

3. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

4.  Thank you for stating the following financial disclosure:

No

a) Please provide an amended Funding Statement that declares *all* the funding or sources of support received during this specific study (whether external or internal to your organization) as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now.  

b) Please state what role the funders took in the study.  If any authors received a salary from any of your funders, please state which authors and which funder. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

5. Please ensure that you refer to Figures 2 and 3 in your text as, if accepted, production will need this reference to link the reader to the figure.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: I Don't Know

Reviewer #2: N/A

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: There is a lot of statistics hidden in the software that is not addressed in the methods. To my impression, these are pre-processed algorithms provided by the manufacturers, which are not clearly presented in the methods section, other than that they are being applied.

The manuscript in my opinion serves best the purpose of a methods paper. However, there is no other validation of the proposed method of inquiry other than the visual confirmation of realistic segmentation by the algorithm based on clinicians estimation.

Throughout the paper there needs to be attention for the use of grammar and typos.

The real valor of these segmentation algorithms would be in the application of pre-surgical planning for tumors with a lot of edema of intraparenchymal invasion. The manuscript would benefit with regard to scientific and translational impact if the authors could demonstrate any feasibility of these algorithms or the applied software to tackle these hurdles.

Reviewer #2: This manuscript is a methodology paper explaining the methods for reconstruction of MRI data for anatomic neurosurgical planning using free, open-source software. This methodology is useful for the field of neurosurgery, and is both less technically challenging and less financially restrictive than other options. This method may potentially be a useful addition to the neurosurgical toolbox, but I find a number of problems with this submission. Primarily, the data used to generate their figures is not made available, and as such their figures cannot be reproduced to validate their methodology. Secondarily, this article could benefit from a significant overhaul by a professional, English-language scientific editor. There are sections of the manuscript where the meaning of the authors is unclear, there are multiple incomplete sentences, and innumerable other grammatical and syntactical errors.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Rutger Balvers

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Dear Editor,

We have studied the valuable comments from you, the assistant editor and reviewers carefully, and tried our best to revise the manuscript. We want to upload all the patient data, but because the Dicom/Nii data of all the patients is too large, we can only upload part of the patient data to verify the repeatability of our study. The point to point responds to the reviewer’s comments are listed as following:

Responds to the reviewer’s comments:

Reviewer 1

Comment 1: There is a lot of statistics hidden in the software that is not addressed in the methods. To my impression, these are pre-processed algorithms provided by the manufacturers, which are not clearly presented in the methods section, other than that they are being applied.

Response: According to the reviewer’s comment, we have added the software instructions, the algorithm of FreeSurfer is very complex; briefly, its processing includes motion correction and averaging of multiple volumetric T1-weighted images (when more than one is available), removal of nonbrain tissue using a hybrid watershed/surface deformation procedure, automated Talairach transformation, and segmentation of the subcortical white matter and deep gray matter volumetric structures. As a clinician, it is difficult to master the running algorithm of the software, and the official website does not mention too much. We were inspired by the simple calculation process provided by the official website. For the extracerebral intracranial tumors without serious peripheral edema, the boundary was clearly separated from the normal brain tissue. After the tumor was artificially labeled and removed, the interface between the normal brain tissue and the tumor is artificially divided. Then, the software could successfully carry out automatic brain tissue segmentation according to its original algorithm.

Comment 2: The manuscript in my opinion serves best the purpose of a methods paper. However, there is no other validation of the proposed method of inquiry other than the visual confirmation of realistic segmentation by the algorithm based on clinicians estimation.

Response: Thank you for your suggestion. We divided the definition of the sulci and gyri into three levels, the cerebral cortex model created by FreeSurfer and 3D volume-rendered images created by 3D Slicer were both evaluated simultaneously by 2 senior and 2 younger neurosurgeons, and scored according to subjective evaluation criteria. The two groups of scores were tested using a two-tailed Wilcoxon signed-rank test. SPSS was used for analysis, both senior and younger neurosurgeons agreed that the brain model created by FreeSurfer was better and had more easily identifiable substructures (p<0.01).

Comment 3: Throughout the paper there needs to be attention for the use of grammar and typos.

Response: Thank you for your careful work. We have submitted the original manuscript to the English translation company for revision.

Comment 4: The real valor of these segmentation algorithms would be in the application of pre-surgical planning for tumors with a lot of edema of intraparenchymal invasion. The manuscript would benefit with regard to scientific and translational impact if the authors could demonstrate any feasibility of these algorithms or the applied software to tackle these hurdles.

Response: Thank you for your advice. However, at present, there is no algorithm that can automatically segment the normal brain tissue from patients with brain tumors. Not just intracranial tumors cannot be segmented, but also extracranial tumors with severe peripheral edema also could not be segmented, because the blood brain barrier has been broken and gray matter boundary is not clear, the task of brain segmentation cannot be completed by Freesurfer software. We have tried to use Freesurfer software to segment the extracranial tumors with severe edema and intracranial tumors, unfortunately, it can only get a defect model of brain tissue or even produce software errors that prevent brain segmentation. Therefore, the proposed method is currently only applicable to brain segmentation of extracranial tumors. Nevertheless, this method can still provide useful information for clinicians, especially when the extracranial tumor is located in a motor and language function areas.

Reviewer 2

Comment 1: Primarily, the data used to generate their figures is not made available, and as such their figures cannot be reproduced to validate their methodology.

Response: According to the reviewer’s comment, we want to upload all the patient data, but because the Dicom/Nii data of all the patients is too large, we can only upload part of the patient data to verify the repeatability of our study.

Comment 2: Secondarily, this article could benefit from a significant overhaul by a professional, English-language scientific editor. There are sections of the manuscript where the meaning of the authors is unclear, there are multiple incomplete sentences, and innumerable other grammatical and syntactical errors.

Response: Thank you for your careful work. We have submitted the original manuscript to the English translation company for revision.

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Jonathan H Sherman, Editor

PONE-D-19-26376R1

A New Simple Brain Segmentation Method for Extracerebral Intracranial Tumors

PLOS ONE

Dear Mrs dongdong,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

We would appreciate receiving your revised manuscript by Mar 19 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled 'Manuscript'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Jonathan H Sherman

Academic Editor

PLOS ONE

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

Reviewer #3: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Partly

Reviewer #3: Partly

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: N/A

Reviewer #3: I Don't Know

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

Reviewer #3: No

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

Reviewer #3: No

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: (No Response)

Reviewer #3: The manuscript would benefit from revision by an English language editor. The authors have made a portion of their data available. The segmentation of the lesions appear accurate but there is no way to validate without the primary imaging data, etc. There is no validation of the method internally by the authors other than a relative neurosurgeon rating score, which is not a validated measure. The argument that this technique can help identify function is only partially accurate. Neurophysiologcial monitoring and awake technique remain pillars of clinical care because anatomy does not always equal function. Receptive speech centers are a classic example. We know that clinically they are not restricted to angular gyrus and supramarginal gyrus but can be represented broadly in the inferior parietal lobule and posterior temporal lobe in the dominant hemisphere.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: No

Reviewer #3: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 2

Dear Editor,

We have studied the valuable comments from you, the assistant editor and reviewers carefully, and tried our best to revise the manuscript. We have uploaded part of the patient data to verify the repeatability of our study.

The point to point responds to the reviewer’s comments are listed as following:

Responds to the reviewer’s comments:

Reviewer 3

Comment 1: The manuscript would benefit from revision by an English language editor.

Response: Thank you for your careful work. We have submitted the original manuscript to the English translation company for revision.

Comment 2: The authors have made a portion of their data available. The segmentation of the lesions appear accurate but there is no way to validate without the primary imaging data, etc.

Response: Thank you for your careful work. DICOM data is raw data, it contains the patient's privacy information. Therefore, we use dcm2nii software to transform DICOM data into “T1.nii” data, and remove the patient's privacy information. With the help of 3D Slicer,tumor was labeled and removed,the new data of “T1 without tumor. nii” is generated and can be loaded into Freesurfer software to segment the brain.

Comment 3: There is no validation of the method internally by the authors other than a relative neurosurgeon rating score, which is not a validated measure.

Response: Thank you for your advice. However, we are just trying to compare the difference of brain model that's been segmented by FreeSurfer software and traditional methods. The neurosurgeon rating score is the most direct and simple way to judge the pros and cons of the two models. In fact, the advantages of the former are obvious. Through literature review, there are similar evaluation methods, just like Karibe et al, in the early stage, used DWI to judge the damage degree of cerebral hemorrhage to corticospinal tract (CST), they also performed CST injury classification by visually observing the relationship between hematoma and CST. (Karibe H, Shimizu H, Tominaga T, et al. Diffusion-weighted magnetic resonance imaging in the early evaluation on of corticospinal tract injury to predict functional motor outcome in patients with deep intracerebral hemorrhage. J Neurosurg.2000;92(1):58-63.) Pandrangi et al. used patients' subjective scores to prove that VR technology is more advantageous in communicating with patients. (Pandrangi VC, Gaston B, Appelbaum NP, Albuquerque FC, Jr., Levy MM, Larson RA. The application of virtual reality in patient education. Ann Vasc Surg. 2019;59: 184-189.)

Comment 4: The argument that this technique can help identify function is only partially accurate. Neurophysiologcial monitoring and awake technique remain pillars of clinical care because anatomy does not always equal function. Receptive speech centers are a classic example. We know that clinically they are not restricted to angular gyrus and supramarginal gyrus but can be represented broadly in the inferior parietal lobule and posterior temporal lobe in the dominant hemisphere.

Response: Thank you for your advice. This is a mistake in writing. We have changed

the summary that the methods we have provided can be used by surgeons as a cheap and easy way to identify the “real” relationship between the extracerebral intracranial lesion and adjacent brain tissue before surgery and improve preoperative planning in any unit. Our method can only provide anatomical segmentation of brain tissue according to different brain structure templates.

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Jonathan H Sherman, Editor

A New Simple Brain Segmentation Method for Extracerebral Intracranial Tumors

PONE-D-19-26376R2

Dear Dr. dongdong,

We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements.

Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication.

Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

With kind regards,

Jonathan H Sherman

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #3: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #3: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #3: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #3: No

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #3: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #3: The article is written in more clearly. They have addressed most of the comments. They apparently cannot provide deidentified imaging data for all patients.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #3: No

Formally Accepted
Acceptance Letter - Jonathan H Sherman, Editor

PONE-D-19-26376R2

A New Simple Brain Segmentation Method for Extracerebral Intracranial Tumors

Dear Dr. Yang:

I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

For any other questions or concerns, please email plosone@plos.org.

Thank you for submitting your work to PLOS ONE.

With kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Jonathan H Sherman

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .